Merck (MRK) stock trades flat as Halozyme Therapeutics (HALO) files patent infringement suit linked to MRK's new injectable ...

Pharmaceuticals giant Merck & Company (MRK) has cut its full-year profit forecasts fearing a $200 million hit from President ...

Merck (MRK) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.07 per share a year ago. These figures are ...

Merck (MRK) stock trades flat as the company lowers earnings outlook amid tariff impact, even as its Q1 2025 results beat ...

Global pharmaceutical company Merck (NYSE:MRK) in Q1 CY2025, but sales fell by 1.6% year on year to $15.53 billion. The ...

Merck is set to release its Q1 2025 earnings before markets open Thursday, with analysts eyeing $2.16 EPS on $15.59B revenue.